Emiko Okabe

发表

Sitagliptin Improves Postprandial Hyperglycemia by Inhibiting Glucagon Secretion in Werner Syndrome With Diabetes

H. Kawamura, K. Yokote, M. Takemoto, 2013, Diabetes Care.

The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: an open label pilot study.

K. Yokote, M. Takemoto, Kazuki Kobayashi, 2012, BioFactors.

An Angiotensin II Type 1 Receptor Blocker Prevents Renal Injury via Inhibition of the Notch Pathway in Ins2 Akita Diabetic Mice

K. Yokote, M. Takemoto, Ryoichi Ishibashi, 2012, Experimental diabetes research.

Atorvastatin ameliorates podocyte injury in patients with type 2 diabetes complicated with dyslipidemia.

H. Kawamura, K. Yokote, M. Takemoto, 2013, Diabetes research and clinical practice.

The clinical characteristics of Asian patients with classical-type Hutchinson–Gilford progeria syndrome

K. Ihara, R. Kosaki, K. Yokote, 2017, Journal of Human Genetics.

Incidence and Characteristics of Metabolic Disorders and Vascular Complications in Individuals with Werner Syndrome in Japan

H. Kawamura, K. Yokote, M. Takemoto, 2012, Journal of the American Geriatrics Society.

Pituitary Adenylate Cyclase-Activating Polypeptide Protects Glomerular Podocytes from Inflammatory Injuries

H. Kawamura, K. Yokote, M. Takemoto, 2015, Journal of diabetes research.

Japanese diabetic patients with Werner syndrome exhibit high incidence of cancer

H. Kawamura, K. Yokote, M. Takemoto, 2012, Acta Diabetologica.

Sitagliptin Successfully Ameliorates Glycemic Control in Werner Syndrome With Diabetes

H. Kawamura, K. Yokote, M. Takemoto, 2012, Diabetes Care.